Mitsubishi Heavy Industries
7011
FUJI Media Holdings
4676
Nippon Telegraph & Telephone
9432
4
SoftBank
9434
5
Remixpoint
3825
JP Stock MarketDetailed Quotes
4884 Kringle Pharma
- 1106
- 00.00%
20min DelayMarket to Open Jan 23 15:30 JST
7.56BMarket Cap-9.36P/E (Static)
0High0Low0Volume0Open1106Pre Close0.00Turnover132852wk High0.00%Turnover Ratio6.84MShares39452wk Low-118.21EPS TTM5.42BFloat Cap1780Historical HighLossP/E (Static)4.90MShs Float394Historical Low-118.21EPS LYR0.00%Amplitude--Dividend TTM3.57P/B100Lot Size--Div YieldTTM
About Kringle Pharma Company
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.
Company Profile
Symbol4884
Company NameKringle Pharma
Founded2001-12-21
MarketTSE Growth
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739
Websitewww.kringle-pharma.com
Company Executives
- Name
- Position
- Salary
- Yoshikazu Adachi
- President and Chief Executive Officer
- --
- Koichi Murakami
- Director and General Manager of Corporate Administration
- --
- Daima Hayata
- Director, General Manager of Pharmaceutical Development Department and General Manager of Pharmaceutical Affairs Department
- --
- Yoshiyuki Kayano
- Director, General Manager of Reliability Assurance Department
- --
- Tomoho Masataku
- Director
- --
- Masato Fukui
- Independent Director
- --
- Koichiro Yoshino
- Independent Director
- --